Active Substance: Oseltamivir Phosphate .
Overview
Welcome to Dwaey, specifically on ENZAFLU 75 mg page.
This medicine contains an important and useful components, as it consists of
Oseltamivir Phosphate
is available in the market in concentration
Oseltamivir
Patient w/ resp disease, chronic cardiac disease. Renal and severe hepatic impairment. Immunocompromised patient. Childn. Pregnancy and lactation. Monitoring Parameters Monitor closely for signs and symptoms of behavioural changes. Lactation: Unknown; use caution
Influenza
Hypersensitivity. Severe renal impairment.
1-10% Abdominal pain,Conjunctivitis,Ear disorder,Epistaxis,Insomnia,Nausea,Vomiting,Vertigo <1% Aggravation of diabetes,Anemia,Arrhythmia,Confusion,Delirium,Hemorrhagic colitis,Hepatitis,Humerus fracture,Peritonsillar abscess,Pneumonia,Pseudomembranous colitis,Pyrexia,Rash,Seizure,Transaminases increased,Toxic epidermal necrolysis,Unstable angina,Swelling of face or tongue Potentially Fatal: Anaphylaxis, severe dermatologic reactions.
3
Oseltamivir is a prodrug of oseltamivir carboxylate (OC). OC is a potent selective competitive inhibitor of neuraminidase (an enzyme required for viral replication) of the influenza virus A and B. It prevents the release of viruses from infected host cell.
May potentially inhibit replication of influenza virus in live/attenuated influenza virus vaccine.
Information not available